Research
The inhibitor blocks Streptococcus mutans from sticking on the tooth surface. About 2.3 billion people worldwide have tooth decay in their permanent teeth, primarily caused by this bacteria.
UAB, Alabama’s leader in precision medicine, joins with Huntsville’s HudsonAlpha in CSER2, an NIH project to bring genomic medicine to more children with birth defects or genetic disorders.
UAB’s long-running study of cannabidiol reveals potential interactions between CBD and some commonly used anti-epileptic drugs.
The Iceberg project is the latest in a line of high-tech freezer technology UAB is working on for NASA.
Improvements in motor function and memory suggest human neurodevelopmental disorders may be amenable to treatment, even after onset of symptoms. According to a researcher, neurodevelopmental disorders with intellectual disability and autism may not need to last a lifetime.

Pediatric neurosurgeons, oncologists and molecular imaging physicians continue to work toward better diagnoses, treatments and cures for childhood cancer.

A UAB physician will co-chair a steering committee of global cystic fibrosis experts and clinical trial investigators to support the design, conduct and execution of the triple combination pivotal study program.
This potential chemotherapeutic agent to treat glioblastoma — a primary brain tumor with dismal survival rates — is a novel small molecule inhibitor.
Antarctica’s Larsen C ice shelf has broken away from the mainland, resulting in a one-trillion ton iceberg.
The International Space Station carries a bit of Birmingham on board — high-tech freezers designed and built by the UAB School of Engineering to protect vital scientific experiments. From their mini mission control, staff and students describe the unique challenges of keeping NASA science on ice for more than 90 space missions.
Page 8 of 95
Back to Top